Here are relevant reports on : insect-protein-market
-
Cancer Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
The global cancer profiling market in terms of revenue was estimated to be worth $9.7 billion in 2022 and is poised to reach $16.0 billion by 2027, growing at a CAGR of 10.6% from 2022 to 2027. The growth in this market is driven by rising funding investments in cancer research and technological advancements in profiling technologies. In addition, the growing need for point-of-care diagnostics is expected to offer significant growth opportunities for market players. On the other hand, a low biomarker discovery-to-approval ratio and a poor regulatory and reimbursement scenario challenge the growth of the cancer profiling market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Electrophoresis Market by Product (Reagents (Protein & Nucleic Acid), (Gel Electrophoresis (1D & 2D), Capillary Electrophoresis (CZE, CGE), GDS, Software), Application (Research, Diagnostics), End User (Hospitals) & Region - Global Forecast to 2028
The global electrophoresis market, valued at US$2.9 billion in 2022, stood at US$3.1 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$4.1 billion by the end of the period. The growth in this market is attributed to the the growing industry-academia research collaboations, and increasing number of clinical, forensic and research labs screening will drive the growth of the market.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Organic Soy Protein Isolates Market by Application (Food & Beverages, Feed), Form (Dry, Liquid), Extraction Process (Qualitative), And Region (North America, Europe, Asia Pacific, South America & RoW) - Global Forecast to 2029
The organic soy protein isolates market size is projected to reach USD 257 million by 2029, and poised to achieve a 5.4% CAGR during the forecast period, The key players in the market are ADM (US), The Scoular Group (US), Xinrui Group (China), Shandong Saigao Group Corporation (China), Taj Agro international (Taj Pharma Group) (India).
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Protein Hydrolysis Enzymes Market by Source (Microorganisms, Animals, Plants), Method of Production (Fermentation and Extraction), Product, Application (Detergent, Pharmaceuticals, Food, Textiles & Leather) and Region - Global Forecast to 2027
The protein hydrolysis enzymes market is projected to reach USD 2.9 billion by 2027, growing at a CAGR of 6.2% during the forecast period. The key players in this market include Novozymes (Denmark), Associated British Foods (UK), DSM (Netherlands), DuPont (US), BASF (Germany), Advanced Enzymes Technologies (India), and Chr. Hansen (Denmark).
- Published: October 2022
- Price: $ 4950
- TOC Available:
-
Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020
The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, at a CAGR of 11.7%. Protein labeling is carried out using labeling reagents and kits to label an antibody or other protein, to make a fluorescent probe, enzyme conjugate, biotinylated binding reagent, or iodine-labeled tracer for detecting proteins in tissues, cells, and biochemical assays.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Respiratory Antivirals Market by Disease Type (URTI, Influenza, Bronchiolitis, Pneumonia, Measles, & Others), Drug Class (Nucleoside Analogues, Neuraminidase Inhibitors, Ion Channel Blockers, Fusion Protein Inhibitors) - Global Forecast to 2019
Over the years, there has been a significant increase in the number of viral respiratory infections in humans. As a result of this, the costs to the community have increased considerably owing to the growing number of physician visits and hospitalizations. Among approximately 200 viral respiratory pathogens, the most important viral pathogens include influenza and respiratory syncytial viruses (RSVs). Antiviral drugs play an important role in the prevention and treatment of these disorders.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) - Global Forecast to 2023
The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of transfer membrane market. The key players in the transfer membrane market include Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India), among others.
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2023
The global microarray analysis market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.6%. The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays. Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
